Download PDF
Thromb Haemost 1980; 44(03): 170
DOI: 10.1055/s-0038-1650116
Letter of the Editor
Schattauer GmbH Stuttgart

Potential Hazards of Antifibrinolytic Treatment in Subarachnoid Haemorrhage

Anna Levati
*   Department of Anaesthetics, Ospedale Niguarda, Milan, Italy
,
Claudio Minella
*   Department of Anaesthetics, Ospedale Niguarda, Milan, Italy
,
Mario Luisa Farina
*   Department of Anaesthetics, Ospedale Niguarda, Milan, Italy
,
Vincenzo D'Angelo
**   Department of Neurosurgery, Ospedale Niguarda, Milan, Italy
› Author Affiliations
Further Information

Publication History

Received 31 July 1980

Accepted 16 October 1980

Publication Date:
13 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Fodstad H, Liliequist B, Schannong M, Thulin C. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms. Surg Neurol 1978; 10: 9-15
    PubMedGoogle Scholar
  • 2 Jotkowitz S. Epsilon aminocaproic acid and possible pulmonary emboli. New Engl J Med 1974; 290: 861
    PubMedGoogle Scholar
  • 3 Farina ML, Levati A, Paino R. Myocardial infarction during antifibrinolytic treatment of subarachnoid haemorrhage. Thromb Haemostas 1979; 42: 1347-1348
    PubMedGoogle Scholar